Early Childhood Obesity Programming by Intrauterine Growth Restriction

Recruiting Observational Study
Childhood Obesity Epigenetics
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 Hour – 24 Months
Sex
Any
Study type
Observational
Participants needed
400 (estimated)
Sponsor
Montefiore Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The molecular mechanisms underlying developmental programming of childhood obesity remain poorly understood. Here, the investigators address major questions about early childhood obesity programming by studying CD3+ T-cells from intrauterine growth restricted (IUGR) newborns who have an increased risk for obesity and other metabolic disorders in adult life.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Mother-infant pairs will be recruited for this study. Inclusion Criteria: * Healthy singleton term intrauterine growth restricted (IUGR) and appropriate for gestational age (AGA) infants whose mothers are followed by the Obstetric Department of Montefiore Medical Center and who deliver at the Weil…
Contacts

Sandra Reznik, MD

718-904-2947

sreznik@montefiore.org

CONTACT